Some Cap-Equipment Vendors Cautious on Pharma s Fourth-Quarter Spending Plans | GenomeWeb

Spending by pharmaceutical companies on life-science research tools appears to be slowly improving as the year nears its conclusion, and that improvement is expected to continue through the fourth quarter, according to industry observers and executives of several firms selling instruments to the pharma market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.